ResMed (RMD)
(Delayed Data from NYSE)
$216.94 USD
-0.04 (-0.02%)
Updated May 6, 2024 04:00 PM ET
After-Market: $216.99 +0.05 (0.02%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth C Momentum C VGM
Brokerage Reports
0 items in cart
ResMed Inc. [RMD]
Reports for Purchase
Showing records 521 - 525 ( 525 total )
Company: ResMed Inc.
Industry: Medical - Products
UnitedHealthcare: Go home, use APAP - New coverage policy positive for ResMed
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
BiancaMed acquisition smart move, despite near-term dilution
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Acquires BiancaMed and new AASM sleep testing legislative effort.
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Wake Up - skip the snooze button with a STRONG BUY, $40.40 PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B